Dronabinol and Lofexidine for Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial()

BACKGROUND: Cannabis use disorder is associated with substantial morbidity and, after alcohol, is the most common drug bringing adolescents and adults into treatment. At present, there are no FDA-approved medications for cannabis use disorder. Combined pharmacologic interventions might be particular...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Alcohol Depend
Egile Nagusiak: Levin, Frances R., Mariani, John J., Pavlicova, Martina, Brooks, Daniel, Glass, Andrew, Mahony, Amy, Nunes, Edward V., Bisaga, Adam, Dakwar, Elias, Carpenter, Kenneth M., Sullivan, Maria A., Choi, Jean C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4729291/
https://ncbi.nlm.nih.gov/pubmed/26711160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.11.025
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak